GEODE CAPITAL MANAGEMENT, LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1214717 BOSTON, MA

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$22,292,212

-$17,019,399 QoQ

Shares Held

2,366,477

+3.8% QoQ

Ownership

2.50%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. FTRE ranks #111 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,292,212	2,366,477	+3.8%	Shares	Defined	2026-05-15
2025-12-31	$39,311,611	2,278,934	+9.4%	Shares	Defined	2026-02-09
2025-09-30	$17,531,913	2,082,175	-4.1%	Shares	Defined	2025-11-12
2025-06-30	$10,726,962	2,171,450	+37.2%	Shares	Defined	2025-08-08
2025-03-31	$11,946,401	1,582,305	+5.9%	Shares	Defined	2025-05-13
2024-12-31	$27,872,443	1,494,501	-0.5%	Shares	Defined	2025-02-12
2024-09-30	$30,050,920	1,502,546	+1.4%	Shares	Defined	2024-11-12
2024-06-30	$34,583,367	1,481,721	+6.9%	Shares	Defined	2024-08-09
2024-03-31	$55,625,409	1,385,785	+3.4%	Shares	Defined	2024-05-13
2023-12-31	$46,764,045	1,339,944	+4.2%	Shares	Defined	2024-02-13
2023-09-30	$36,767,254	1,286,018	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.